Latest Financial Results
Q1 2023
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2022
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company Overview
Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company that applies its technology to discover and develop novel, high performance enzymes and biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of small molecule pharmaceuticals, in RNA and DNA synthesis and the creation of next generation life science tools, and as gene therapies and oral enzyme therapies. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved return on capital in manufacturing, improved sensitivity in genomic and diagnostic applications, and more efficacious therapeutics.
IR Contacts
Headquarters
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
United States
T: 650-421-8100
Lauren Musto
media@codexis.com
Investor Relations
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
T: 650-421-8399
Carrie McKim
ir@codexis.com
Transfer Agent
EQ Shareowner Services
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120-4100
T: 800-468-9716
https://www.shareowneronline.com